Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12188/11058
DC FieldValueLanguage
dc.contributor.authorSvetlana Stankovicen_US
dc.contributor.authorLidija Cevreskaen_US
dc.contributor.authorTatjana Smilevskaen_US
dc.contributor.authorAleksandar Stojanovicen_US
dc.contributor.authorOliver Karanfilskien_US
dc.contributor.authorBorce Georgievskien_US
dc.contributor.authorArif Ljatifien_US
dc.date.accessioned2021-03-18T12:02:50Z-
dc.date.available2021-03-18T12:02:50Z-
dc.date.issued2006-
dc.identifier.urihttp://hdl.handle.net/20.500.12188/11058-
dc.language.isoenen_US
dc.relation.ispartofTurkish Journal of Hematologyen_US
dc.subjectBondronaten_US
dc.subjectmultiple myelomaen_US
dc.subjectaccessory treatmenten_US
dc.titleBondronat is essential accesory treatment in multiple myeloma with negligible side effectsen_US
dc.typeProceeding articleen_US
dc.relation.conference1st balkan Hematology Days, Antalya, Turkey, Nov 10-11, 2006en_US
item.fulltextWith Fulltext-
item.grantfulltextopen-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
Appears in Collections:Faculty of Medicine: Conference papers
Show simple item record

Page view(s)

42
checked on Sep 19, 2023

Download(s)

9
checked on Sep 19, 2023

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.